Drawing for BRIGHTMIND.AI

USPTO serial 79369271

BRIGHTMIND.AI

Reviewed by CopyMark Law Group

Reg. 7525621Status 700Registered
Filing date
Status date
Registration date
Oct 8, 2024
Examiner
MARSH, LAURA KATHLEEN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BRIGHTMIND.AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeremy Peter Green Eche

Jeremy Peter Green Eche JPG Legal163 23rd St.Brooklyn, NY 11232United States

Goods and services

ClassDescriptionStatusFirst use
009Electromagnetic coils; electronic databases in the field of neuromodulation in neurological diseases recorded on computer media; downloadable computer software programs for patient profiling and neurological disease management; apparatus and instruments for research purposes, namely, electroencephalography (EEG) apparatus, neurostimulators and brain-computer interface (BCI) apparatus; electronic control instruments for influencing and interacting of the human brain; neural helmets, not for medical purposes; digital sensors for detecting brain waves and health parameters; downloadable artificial intelligence software for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence software for use in the field of healthcare, namely, for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence and machine learning software for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence software for analysis of personal health and lifestyle data; downloadable software for the integration of artificial intelligence and machine learning in the field of Big DataACTIVE—
010Low-frequency electromagnetic therapy apparatus; transcutaneous electrical nerve stimulators; transcutaneous electrical nerve stimulation apparatus; diagnostic apparatus for medical purposes for testing neurological conditions; medical electrodes; medical instruments, namely, transcranial magnetic stimulation (TMS) apparatus, electroencephalography (EEG) apparatus, neurostimulators, brain-computer interface (BCI) apparatus; medical apparatus; testing apparatus for medical purposes; apparatus for analyzing brain wave frequencies; apparatus for the diagnosis of cerebrovascular diseases; brain pacemakers; transcutaneous electrical nerve stimulation electrodes; electrotherapy stimulation apparatus comprising electrical nerve stimulators; electrical apparatus for nerve stimulation for rehabilitative and pain management, disease modifying, stabilization and improvement in neurological and psychiatric conditions purposes; electronic nerve stimulators for medical use; apparatus for nerve location, namely, transcranial magnetic stimulation (TMS) apparatus; neural helmets for medical purposes; medical apparatus for neurographic purposes, namely, electroencephalography (EEG) apparatus; apparatus for the diagnosis of neurological diseases; medical apparatus and instruments relating to neurovegetative reactivityACTIVE—
042Data mining; development and testing of computing methods, algorithms and software; platform as a service (PAAS) services featuring software platforms for AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; software as a service (SAAS) services featuring software for AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; computer software development; research and development of new products; medical and scientific research, namely, conducting clinical trials for others; scientific research and development; scientific research for medical purposes in the field of neurological and psychiatric disorders; research in the field of artificial intelligence technology; platforms for artificial intelligence as software as a service (SAAS) services featuring computer software platforms for {AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; medical research; technological research in the field of {neurological and psychiatric disorders; software as a service (SAAS) services featuring software for deep neural networks; software as a service (SAAS) services featuring software for machine learning, deep learning and deep neural networksACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 4, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 17, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 17, 2025FIMPFINAL DISPOSITION PROCESSED—
Jan 8, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 8, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 8, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 20, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jun 20, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 20, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 20, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 6, 2024RFNTREFUSAL PROCESSED BY IB—
Jan 12, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 12, 2024RFRRREFUSAL PROCESSED BY MPU—
Dec 28, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2023DOCKASSIGNED TO EXAMINER—
May 16, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
May 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance